LGL Group, a holding company focused on business operations and merchant investments, will participate in the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference in New York City on September 9-10, 2026. CEO Jason Lamb will deliver an investor presentation highlighting the company's strategic focus on critical technologies and growth through its Platform Operations and Merchant Investment activities. This event connects innovators and investors in biotech, medical devices, and healthcare technology, providing LGL Group an opportunity to showcase its business and attract potential investors. The company aims to enhance shareholder value through disciplined capital allocation and operational excellence.
Medtronic reported Q3 earnings per share of $1.45, surpassing estimates of $1.39, and revenue of $9.76 billion, above the $9.55 billion consensus. The strong financial results reflect broad demand for its cardiovascular devices. The company raised it...
Dell Technologies is expected to report record second-quarter earnings with EPS around $4.91 and revenue near $44.89 billion, fueled by high demand for its AI-optimized servers. This would mark a significant increase from last year's $29.78 billion a...
Protagonist Therapeutics saw its stock price target raised to $180 by Barclays following the FDA approval of MIMRYLO, a first-in-class drug for polycythemia vera. The approval was based on strong Phase 3 trial results with 76.9% patient response, tri...
Science Applications International Corporation (SAIC) saw its price target raised to $154 after reporting Q2 earnings of $3.01 per share, surpassing estimates by over 33%, and revenues of $1.88 billion, beating expectations by 7.52%. The company also...
UBS upgraded Hercules Capital's rating from Neutral to Buy, reflecting confidence in the company's strong financial stability and growth prospects. Hercules Capital, a specialty finance firm supporting tech and life sciences startups, boasts a BBB+ c...
